Cable Hill Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $471K | Sell |
924
-101
| -10% | -$51.5K | 0.05% | 97 |
|
|
2024
Q4 | $413K | Buy |
1,025
+1
| +0.1% | +$403 | 0.04% | 104 |
|
|
2024
Q3 | $476K | Buy |
1,024
+7
| +0.7% | +$3.26K | 0.05% | 92 |
|
|
2024
Q2 | $477K | Buy |
+1,017
| New | +$477K | 0.05% | 91 |
|
|
2023
Q4 | – | Sell |
-1,173
| Closed | -$408K | – | 245 |
|
|
2023
Q3 | $408K | Buy |
1,173
+187
| +19% | +$65K | 0.06% | 87 |
|
|
2023
Q2 | $347K | Sell |
986
-267
| -21% | -$94K | 0.05% | 114 |
|
|
2023
Q1 | $395K | Sell |
1,253
-35
| -3% | -$11K | 0.06% | 99 |
|
|
2022
Q4 | $372K | Buy |
1,288
+26
| +2% | +$7.51K | 0.07% | 108 |
|
|
2022
Q3 | $365K | Buy |
1,262
+141
| +13% | +$40.8K | 0.07% | 87 |
|
|
2022
Q2 | $316K | Buy |
1,121
+183
| +20% | +$51.6K | 0.08% | 100 |
|
|
2022
Q1 | $245K | Buy |
938
+9
| +1% | +$2.35K | 0.16% | 106 |
|
|
2021
Q4 | $204K | Buy |
+929
| New | +$204K | 0.04% | 149 |
|
|
2019
Q2 | – | Sell |
-219
| Closed | -$40K | – | 685 |
|
|
2019
Q1 | $40K | Sell |
219
-12
| -5% | -$2.19K | 0.01% | 282 |
|
|
2018
Q4 | $38K | Buy |
231
+11
| +5% | +$1.81K | 0.02% | 272 |
|
|
2018
Q3 | $41K | Sell |
220
-230
| -51% | -$42.9K | 0.02% | 205 |
|
|
2018
Q2 | $76K | Sell |
450
-37
| -8% | -$6.25K | 0.03% | 141 |
|
|
2018
Q1 | $75K | Sell |
487
-66
| -12% | -$10.2K | 0.03% | 145 |
|
|
2017
Q4 | $85K | Sell |
553
-73
| -12% | -$11.2K | 0.04% | 159 |
|
|
2017
Q3 | $95K | Buy |
626
+482
| +335% | +$73.1K | 0.04% | 169 |
|
|
2017
Q2 | $18K | Buy |
144
+124
| +620% | +$15.5K | 0.01% | 278 |
|
|
2017
Q1 | $2K | Hold |
20
| – | – | ﹤0.01% | 686 |
|
|
2016
Q4 | $1K | Sell |
20
-5
| -20% | -$250 | ﹤0.01% | 705 |
|
|
2016
Q3 | $2K | Buy |
25
+5
| +25% | +$400 | ﹤0.01% | 728 |
|
|
2016
Q2 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 641 |
|